A majority also identified opportunities to extend professional roles (83.3%), opportunities for more effective patient treatment (78.5%), opportunities to better meet patient expectations (74.4%) and financial advantage to their pharmacy (52.6%) as benefits of e-MAS. Suspected misuse/overuse of the service by some customers (75.1%) and time required for recording each consultation or supply (61.3%) were two barriers agreed upon by the majority of the respondents. Conclusions  A majority of respondents

had positive views towards e-MAS. The benefits agreed upon by the majority of the respondents relate to known AZD6244 facilitators of community pharmacy practice change. Major barriers, namely suspected misuse of the

service by some customers and timely process for recording consultation or supply, could affect pharmacists’ efficiency in service delivery and need to be addressed. These results could inform similar schemes that may be introduced locally in the UK or elsewhere. “
“To identify modifiable factors that influence patients’ information-giving behaviour about their health during consultations with pharmacy staff. A theory of planned behaviour questionnaire was posted to 3000 individuals randomly selected from the Scottish Electoral Register. The 927 respondents confirmed a low rate of disclosure of information about their health to pharmacy staff during their last pharmacy visit. Individuals who intended to give information about their health during pharmacy consultations were more likely to do so. Those who intended to give selleck inhibitor information during consultations had higher Tacrolimus (FK506) subjective norms than those who did not (i.e. intentions were associated with beliefs that people who were important to them, e.g. family members, doctors, thought they should give information during these consultations). Control beliefs, e.g. ‘I am confident

that I will give information if I have received good advice in the past’, and behavioural beliefs, e.g. ‘If I give information I will be sold an appropriate medicine’, were not associated with intention or behaviour. Future interventions to promote relevant communication between patients and pharmacy staff should target patients’ subjective norms rather than control beliefs or behavioural beliefs. The extent to which patients communicate with community pharmacy staff during consultations for non-prescription medicines (NPMs) has been shown to influence the outcome of the consultation in terms of whether an appropriate medicine is sold and/or appropriate counselling (i.e. advice) is given.[1-4] The inappropriate supply and use of NPMs can delay access to correct treatment and lead to adverse drug reactions.[5] Pharmacy staff’s information elicitation and advice provision (hereafter referred to as counselling) behaviour can affect clinical outcomes as well as patient and professional satisfaction.